Terms: = Prostate cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2
23 results:
1. Ketorolac modulates Rac-1/HIF-1α/ddx3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma.
Sonawane V; Ghosalkar J; Achrekar S; Joshi K
Sci Rep; 2023 Apr; 13(1):5659. PubMed ID: 37024613
[TBL] [Abstract] [Full Text] [Related]
2. A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL.
Miyoshi Y; Kawahara T; Uemura H
BMC Cancer; 2022 Nov; 22(1):1169. PubMed ID: 36371158
[TBL] [Abstract] [Full Text] [Related]
3. Label-free discrimination of tumorigenesis stages using in vitro prostate cancer bone metastasis model by Raman imaging.
Kar S; Jaswandkar SV; Katti KS; Kang JW; So PTC; Paulmurugan R; Liepmann D; Venkatesan R; Katti DR
Sci Rep; 2022 May; 12(1):8050. PubMed ID: 35577856
[TBL] [Abstract] [Full Text] [Related]
4. lncRNA HLA Complex Group 18 (HCG18) Facilitated Cell Proliferation, Invasion, and Migration of prostate cancer Through Modulating miR-370-3p/ddx3x Axis.
Pan X; Chen G; Hu W
Reprod Sci; 2021 Dec; 28(12):3406-3416. PubMed ID: 34708395
[TBL] [Abstract] [Full Text] [Related]
5. Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient prostate cancer.
Sena LA; Fountain J; Isaacsson Velho P; Lim SJ; Wang H; Nizialek E; Rathi N; Nussenzveig R; Maughan BL; Velez MG; Ashkar R; Larson AC; Pritchard CC; Adra N; Bryce AH; Agarwal N; Pardoll DM; Eshleman JR; Lotan TL; Antonarakis ES
Oncologist; 2021 Feb; 26(2):e270-e278. PubMed ID: 33215787
[TBL] [Abstract] [Full Text] [Related]
6. RNA-binding protein ddx3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.
Vellky JE; McSweeney ST; Ricke EA; Ricke WA
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28092-28101. PubMed ID: 33106406
[TBL] [Abstract] [Full Text] [Related]
7. Cribriform pattern and perineural invasion on MR/US fusion biopsy predict failure of selection criteria for prostatic hemigland ablation.
Mithal P; Truong M; Quarrier S; Lu D; Hollenberg G; Weinberg E; Miyamoto H; Frye T
Urol Oncol; 2020 Feb; 38(2):38.e1-38.e8. PubMed ID: 31753604
[TBL] [Abstract] [Full Text] [Related]
8. Development and external validation of a nomogram to predict lymph node invasion after robot assisted radical prostatectomy.
Tosco L; Devos G; De Coster G; Roumeguère T; Everaerts W; Quackels T; Dekuyper P; Van Cleynenbreugel B; Van Damme N; Van Eycken E; Ameye F; Joniau S;
Urol Oncol; 2020 Feb; 38(2):37.e11-37.e20. PubMed ID: 31727561
[TBL] [Abstract] [Full Text] [Related]
9. Expression and Localization of ddx3 in prostate cancer Progression and Metastasis.
Vellky JE; Ricke EA; Huang W; Ricke WA
Am J Pathol; 2019 Jun; 189(6):1256-1267. PubMed ID: 30926334
[TBL] [Abstract] [Full Text] [Related]
10. PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with prostate cancer on Active Surveillance.
Lokman U; Erickson AM; Vasarainen H; Rannikko AS; Mirtti T
Eur Urol Focus; 2018 Dec; 4(6):867-873. PubMed ID: 28753869
[TBL] [Abstract] [Full Text] [Related]
11. RK-33 Radiosensitizes prostate cancer Cells by Blocking the RNA Helicase ddx3.
Xie M; Vesuna F; Tantravedi S; Bol GM; Heerma van Voss MR; Nugent K; Malek R; Gabrielson K; van Diest PJ; Tran PT; Raman V
Cancer Res; 2016 Nov; 76(21):6340-6350. PubMed ID: 27634756
[TBL] [Abstract] [Full Text] [Related]
12. Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.
Xie M; Lapidus RG; Sadowska M; Edelman MJ; Hosmane RS
Bioorg Med Chem; 2016 Jun; 24(12):2595-602. PubMed ID: 27134120
[TBL] [Abstract] [Full Text] [Related]
13. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J
Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480
[TBL] [Abstract] [Full Text] [Related]
14. Sextant-Specific Analysis of Detection and Tumor Volume by HistoScanning™.
Porres D; Kuru TH; Epplen R; Eck A; Zugor V; Kennes LN; Afram S; Braunschweig T; Knüchel-Clarke R; Pfister D; Heidenreich A
Urol Int; 2016; 96(2):194-201. PubMed ID: 26555799
[TBL] [Abstract] [Full Text] [Related]
15. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
Key TJ; Appleby PN; Travis RC; Albanes D; Alberg AJ; Barricarte A; Black A; Boeing H; Bueno-de-Mesquita HB; Chan JM; Chen C; Cook MB; Donovan JL; Galan P; Gilbert R; Giles GG; Giovannucci E; Goodman GE; Goodman PJ; Gunter MJ; Hamdy FC; Heliövaara M; Helzlsouer KJ; Henderson BE; Hercberg S; Hoffman-Bolton J; Hoover RN; Johansson M; Khaw KT; King IB; Knekt P; Kolonel LN; Le Marchand L; Männistö S; Martin RM; Meyer HE; Mondul AM; Moy KA; Neal DE; Neuhouser ML; Palli D; Platz EA; Pouchieu C; Rissanen H; Schenk JM; Severi G; Stampfer MJ; Tjønneland A; Touvier M; Trichopoulou A; Weinstein SJ; Ziegler RG; Zhou CK; Allen NE;
Am J Clin Nutr; 2015 Nov; 102(5):1142-57. PubMed ID: 26447150
[TBL] [Abstract] [Full Text] [Related]
16. Oncological outcome after primary prostate cryoablation compared with radical prostatectomy: a single-centre experience.
Elkjær MC; Borre M
Scand J Urol; 2014 Feb; 48(1):27-33. PubMed ID: 23597178
[TBL] [Abstract] [Full Text] [Related]
17. Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.
Kader AK; Sun J; Reck BH; Newcombe PJ; Kim ST; Hsu FC; D'Agostino RB; Tao S; Zhang Z; Turner AR; Platek GT; Spraggs CF; Whittaker JC; Lane BR; Isaacs WB; Meyers DA; Bleecker ER; Torti FM; Trent JM; McConnell JD; Zheng SL; Condreay LD; Rittmaster RS; Xu J
Eur Urol; 2012 Dec; 62(6):953-61. PubMed ID: 22652152
[TBL] [Abstract] [Full Text] [Related]
18. Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature.
Yates DR; Gregory GC; Roupret M; Malki MM; Haynes MD; Hamdy FC; Rosario DJ
Urol Oncol; 2013 Jul; 31(5):542-8. PubMed ID: 21493112
[TBL] [Abstract] [Full Text] [Related]
19. Urinary incontinence after radical prostatectomy: can men at risk be identified preoperatively?
Moore KN; Truong V; Estey E; Voaklander DC
J Wound Ostomy Continence Nurs; 2007; 34(3):270-9; quiz 280-1. PubMed ID: 17505246
[TBL] [Abstract] [Full Text] [Related]
20. Controversies in prostate cancer staging implementation at a tertiary cancer center.
Sexton T; Rodrigues G; Brecevic E; Boyce L; Parrack D; Lock M; D'Souza D
Can J Urol; 2006 Dec; 13(6):3327-34. PubMed ID: 17187696
[TBL] [Abstract] [Full Text] [Related]
[Next]
